Live feed16:05:00·1dPRReleasevia QuantisnowViridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred StockByQuantisnow·Wall Street's wire, on your screen.VRDN· Viridian Therapeutics Inc.Health Care
